Dangerous drugs, compromised regulators
The Telegraph July 31, 2019 By Sevanti Ninan The average consumer of medication in this country does not lose much sleep over drug quality or how drug regulators are doing their job. A new book out in the United States and now available here could change some of that. Katherine Eban’s Bottle of Lies is a racy account of the functioning of an increasingly ethics-immune drug industry whose actions have life and death consequences. While it excels in storytelling, colourfully reconstructing sequences where its dramatis personae confront skullduggery by leading drug manufacturers, there is reams of solid investigation at its core. It is written primarily for drug consumers in the United States who are driven by the exorbitant costs of health care in their own country to use generic drugs manufactured in India and China. But the Indian companies it names---Ranbaxy, Wockhardt Ltd, Dr Reddy’s, RPG Lifesciences ---manufacture for the India market as well. The...